還沒有賬號立即注冊
登錄即代表您已同意《leyu·樂魚(中國)體育官方網(wǎng)站隱私政策》
登錄即代表您已同意《leyu·樂魚(中國)體育官方網(wǎng)站隱私政策》
已有賬號登錄賬號
ERP solves the challenges of every enterprise
Gaoji Pharmaceutical Co., Ltd
Established on September 5, 2017, the founding team comes from top medical, pharmaceutical, and retail groups in China, with deep investment and operational capabilities in the field of big health.
Gaoji Medical is a subsidiary of Hillhouse Capital that focuses on strategic investment and operation in the field of big health. It has established equity partnerships with multiple high-quality chain enterprises nationwide and has built regional market platforms in multiple provinces, deeply participating in the integration of local pharmaceutical retail markets. Unlike general financial investors, Gaoji Medical will serve as a business partner for cooperative enterprises, focusing on building industry platforms and participating in long-term operations. Gaoji attaches great importance to establishing a professional headquarters operation and control team, providing professional support for business in areas such as operations, financial management, human resource management, and information construction; And establish regional operation and control platforms in North China, East China, South China, and Southwest to promote regional business integration. Combining the investment experience of Hillhouse Capital in TMT and large consumer industries, the health management knowledge base system of Mayo and Huimei Medical, the technical reserves of IT big data applications, and the operational capabilities of the medical services and pharmaceutical industries, Gaoji Medical can achieve rapid investment project landing, stable business integration, improved operational efficiency, and continuous performance improvement, creating long-term value for shareholders, employees, and customers.
Gaoji Medical only took less than two years. Tens of thousands of physical pharmacies are located in 21 provinces and cities across the country, with a total revenue of nearly 30 billion yuan in 2018.
